Is Your 340B Vendor A Partner Or A Parasite?
Proxsys Rx
MAY 16, 2024
Why 340B vendors charging Percentage Of Revenue is wrong. And that is why, we believe, it’s so wrong for 340B vendors charging Percentage Of Revenue (let’s call it POOR for short) on every retail and specialty drug purchased — 340B or otherwise. Should a profitable 340B vendor share none of its clients’ risk?
Let's personalize your content